10 Biotech Stocks Expected to at Least Double

Description:

According to Jake Lynch, "Investing in biotechnology stocks is a tricky game. Many biotech companies are unprofitable and burn through cash, appearing destined for shareholder dilution or bankruptcy court. Yet, those that do succeed deliver obscene returns. ... Here are 10 of the highest-rated biotech stocks. They're exceptionally risky, but are predicted by analysts to double, triple, quadruple or even quintuple in the next 12 months." Read more here.

>>Also: 10 Pharma Stocks With Up to 88% Upside

SymbolStart PriceReturn Value
Symbols Added Since Tracking Began
SNGX
CYCC
NVAX
AVNR
CRIS
ATHX
OGXI
NABI
NBY
NGSX

Average Return: 0.00%

Success Rate: 0.00%

Tracking Started: 10-20-2010

Most Viewed Portfolios

View All

Articles

Must-See Charts: 5 Big Stocks to Sidestep the Selloff

09.23.14 | 09:47 AM

BALTIMORE (Stockpickr) -- Yesterday was an ugly day for stocks -- and not because of the 0.8% drop in the S&P 500. Even though that drop wasn't pre...

4 Health Care Stocks Triggering Breakout Trades on Unusual Volume

09.23.14 | 08:35 AM

DELAFIELD, Wis. (Stockpickr) -- Professional traders running mutual funds and hedge funds don't just look at a stock's price moves; they also track...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter